C4 Therapeutics, Inc.

Ownership Transactions Reported by 25 Insiders

Symbol
CCCC on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
490 Arsenal Way, Suite 120, Watertown, MA

Insiders trading volume in the past year

C4 Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Marc A. Cohen Director $12.9M Jun 22, 2022
Alain J. Cohen Director $11.8M Apr 4, 2022
Glenn Dubin Director $6.58M Apr 1, 2024
Elena Prokupets Director $3.49M Sep 27, 2021
Andrew Hirsch President & CEO, Director $1.54M Feb 14, 2025
Stewart Fisher Chief Scientific Officer $922K Sep 16, 2024
Kendra Adams Chief Financial Officer $588K Feb 13, 2025
Leonard Reyno Chief Medical Officer $553K Feb 14, 2025
Kenneth Carl Anderson Director $475K Apr 1, 2025
Kelly Schick Chief People Officer $410K Feb 13, 2025
Jolie Siegel Chief Legal Officer $407K Feb 13, 2025
Scott N. Boyle Chief Business Officer $403K -$3.65K -0.9% Feb 13, 2025
Paige Mahaney Chief Scientific Officer $334K Feb 14, 2025
Lauren White Chief Financial Officer $318K Aug 30, 2023
Adam Crystal Chief Medical Officer $250K Jan 30, 2023
Donna Roy Grogan Director $60.7K Apr 1, 2025
Mark Mossler Chief Accounting Officer $57.9K Feb 14, 2025
Malcolm Salter Director Jun 20, 2024
Steven L. Hoerter Director Nov 19, 2024
Stephen Fawell Director Aug 29, 2024
Utpal Koppikar Director Jun 20, 2024
Ronald Harold Wilfred Cooper Director Jun 7, 2024
Owen Hughes Director Jun 20, 2024
Laura Bessen Director Jun 20, 2024
Bruce Downey Director Jun 20, 2024

Recent Insider Transactions by Companies or Individuals for C4 Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.